Taking nature's lead in the development of new and improved enzyme inhibitors
The University of Adelaide
Australian Research Council
Abell, Prof Andrew D; George, Dr Jonathan
This project will address some key fundamental issues associated with advancing a chemical entity from proof of principle through to a new pharmaceutical. The compounds in the study target cancer, cataract and other diseases that are confronting Australia's ageing population.